Chronic Total Occlusion (CTO) Devices Manufacturers & Exporters

Featured CTO & Vascular Solutions

🌐The Global Landscape of Chronic Total Occlusion (CTO) Devices

The global medical community defines Chronic Total Occlusion (CTO) as a complete or near-complete blockage of a coronary or peripheral artery that has been present for at least three months. Historically, CTOs were considered the "final frontier" of interventional cardiology due to their high procedural complexity and lower success rates compared to non-occlusive lesions. However, the industrial landscape has shifted dramatically.

Market Growth

The global CTO devices market is projected to grow at a CAGR of over 7.5% through 2030, driven by an aging population and the rising prevalence of Coronary Artery Disease (CAD).

Technological Barriers

Manufacturing CTO devices requires extreme precision. Microcatheters and guidewires must balance "pushability," "torqueability," and "trackability" to navigate calcified lesions.

Clinical Expertise

Modern CTO procedures utilize advanced techniques like Antegrade Wire Escalation (AWE) and Retrograde approaches, demanding specialized equipment for each step.

🚀Industry Development Trends

As a leading manufacturer, we observe several key trends shaping the future of CTO interventions:

Miniaturization: Development of ultra-low profile balloon catheters and microcatheters to access distal vessels.
Specialized Coating Technology: Hydrophilic coatings that reduce friction, allowing devices to glide through tight stenoses without damaging the vessel wall.
AI-Guided Navigation: Integration of artificial intelligence in cath labs to provide real-time 3D mapping of occluded segments.
Drug-Eluting Innovations: The shift toward drug-coated balloons (DCB) for CTO to minimize late lumen loss and restenosis.

About Hangzhou SJ Medical Co., Ltd.

Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.

Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.

2015 Established

5,000㎡ Factory Area

CE/ISO Certified

20+ Global Markets

🏭Our Manufacturing Excellence

SJ Medical operates a modern manufacturing facility built in accordance with GMP standards. Our facility features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.

Advanced Equipment

Equipped with precision balloon forming equipment, laser welding, and marking technologies to ensure high levels of manufacturing accuracy.

Expert Team

Our technical team consists of industry veterans with decades of experience in medical device engineering and clinical application.

Quality Control

Full-process quality control from raw material inspection to final sterilization, ensuring product reliability and consistency.

🌍Global Procurement & Localized Applications

As a premier CTO devices exporter, we understand the diverse needs of global procurement officers and clinicians. The demand for high-quality interventional tools is not uniform; it varies by region and clinical setting.

Localized Application Scenarios:

European Specialized Heart Centers: Demand for high-end microcatheters for complex retrograde CTO procedures where precision and flexibility are paramount.
Emerging Markets (Asia & Middle East): A high volume of patients with advanced CAD requires cost-effective yet highly reliable balloon catheters and guidewires to improve procedural success rates in public hospitals.
Ambulatory Surgical Centers (ASCs): Increasing demand for peripheral CTO devices to treat Critical Limb Ischemia (CLI) in outpatient settings, focusing on rapid recovery and safety.

Why Global Buyers Choose Chinese Manufacturers:

The shift toward Chinese medical device manufacturing is driven by the "Value-Based Healthcare" model. Companies like SJ Medical offer:

Supply Chain Stability: Robust local sourcing of medical-grade polymers and metals ensures uninterrupted production.
Rapid R&D Iteration: We can move from clinical feedback to prototype refinement faster than traditional Western giants.
Regulatory Compliance: With CE, ISO 13485, and CFDA approvals, our products meet the stringent safety requirements of global healthcare systems.

Product Portfolio & Global Reach

SJ Medical focuses on the development of vascular interventional devices designed for both coronary and peripheral procedures. Each product is developed with an emphasis on precision, safety, and clinical performance.

Coronary Intervention

PTCA Balloon Catheters, CTO Guidewires, and Microcatheters designed for complex lesion crossing.

Peripheral Intervention

PTA Balloon Catheters and access systems for treating Peripheral Artery Disease (PAD).

Diagnostic & Access

Diagnostic catheters and introducer sheaths that provide the foundation for successful procedures.

Our products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt. We continue to expand our international footprint to support physicians in achieving optimal procedural outcomes.